重组Anti-ATP7A抗体[EPR27493-139] - BSA and Azide free
Anti-ATP7A antibody [EPR27493-139] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- 了解详情
Be the first to review this product! Submit a review
|
(0 Publication)
Knockout Tested Rabbit Recombinant Monoclonal ATP7A antibody. Carrier free. Suitable for WB, ICC/IF and reacts with Human, Mouse samples.
查看别名
MC1, MNK, ATP7A, Copper-transporting ATPase 1, Copper pump 1, Menkes disease-associated protein
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-ATP7A antibody [EPR27493-139] - BSA and Azide free (AB308525)
This data was developed using ab308524, the same antibody clone in a different buffer formulation. Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized SH-SY5Y (human neuroblastoma epithelial cell) cells labelling ATP7A with ab308524 at 1/500 (9.88 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2ug/ml dilution (Green). Confocal image showing cytoplasmic staining in SH-SY5Y cell line, no staining was observed in HepG2 cell line. Low expression : HepG2 (PMID : 9693104). Image was taken with a confocal microscope(Leica-Microsystems, TCS SP8). ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2ug/ml dilution.
- WB
Lab
Western blot - Anti-ATP7A antibody [EPR27493-139] - BSA and Azide free (AB308525)
This data was developed using the same antibody clone in a different buffer formulation (ab308524).
Western blot : Anti-ATP7A antibody [EPR27493-139] (ab308524) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab308524 was shown to bind specifically to ATP7A. A band was observed at 163 kDa in wild-type A549 cell lysates with no signal observed at this size in ATP7A knockout cell line. To generate this image, wild-type and ATP7A knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-ATP7A antibody [EPR27493-139] (<a href='/products/primary-antibodies/atp7a-antibody-epr27493-139-ab308524'>ab308524</a>) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
ATP7A knockout A549 cell lysate at 20 µg
Lane 3:
HCT116 cell lysate at 20 µg
Lane 4:
A549 Nuclear cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 163 kDa
false
- WB
Supplier Data
Western blot - Anti-ATP7A antibody [EPR27493-139] - BSA and Azide free (AB308525)
This data was produced using ab308524, the same antibody clone but in a different formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The molecular weight observed is consistent with the literature (PMID : 16371425).
The identity of the bands between 37 kDa and 100 kDa are unknown.
Samples are non-boiled as boiling may cause protein aggregation.
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
In Western blot, anti-GAPDH antibody (ab181602) loading control staining at 1/200000 dilution.
All lanes:
Western blot - Anti-ATP7A antibody [EPR27493-139] (<a href='/products/primary-antibodies/atp7a-antibody-epr27493-139-ab308524'>ab308524</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa transfected with siRNA specifically targeting ATP7A whole cell lysate at 20 µg
Lane 3:
Mouse lung tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 163 kDa
Observed band size: 140-170 kDa
true
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-ATP7A antibody [EPR27493-139] - BSA and Azide free (AB308525)
This data was produced using ab308524, the same antibody clone but in a different formulation. Blocking and diluting buffer and concentration : 5% NFDM/TBST. Low expression : HepG2 (PMID : 9693104). The molecular weight observed is consistent with the literature (PMID : 16371425). The lanes 3-5 were developed using a high sensitivity ECL substrate. The identity of the bands between 37 kDa and 100 kDa are unknown. Samples are non-boiled as boiling may cause protein aggregation. In Western blot, anti-GAPDH antibody (ab181602) loading control staining at 1/200000 dilution. Exposure time : 180 seconds.
All lanes:
Western blot - Anti-ATP7A antibody [EPR27493-139] (<a href='/products/primary-antibodies/atp7a-antibody-epr27493-139-ab308524'>ab308524</a>) at 1/1000 dilution
Lane 1:
SH-SY5Y (human neuroblastoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HepG2 (human hepatocellular carcinoma epithelial cell), whole cell lysate at 20 µg
Lane 3:
RAW 264.7 (mouse abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Lane 4:
NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 5:
Neuro-2a (mouse neuroblastoma neuroblast), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 163 kDa
Observed band size: 140-170 kDa
false
Exposure time: 180s
不同偶联物与剂型 (1)
-
Anti-ATP7A antibody [EPR27493-139]
反应性数据
产品详情
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ATP7A is essential in maintaining copper homeostasis across multiple systems. It is involved in supplying copper to enzymes like lysyl oxidase which is important for connective tissue development. ATP7A does not function as a part of a larger complex but it coordinates closely with cellular mechanisms ensuring appropriate copper levels. Its movement between golgi apparatus and the cell membrane allows for effective intracellular copper management.
Pathways
ATP7A influences copper metabolic pathways and is specifically important in the absorption and distribution of copper. It works with another transporter protein ATP7B to maintain copper balance by exporting excess copper into the bile and plasma. Both proteins are critical in copper regulation and show complementary functions in preventing copper toxicity.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com